Cited by 433Neurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal PhysiologyNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.

Understanding opioid reward

Open access

Fields, Howard L., Margolis, Elyssa B.·2015·Trends in Neurosciences

DOI 10.1016/j.tins.2015.01.002PMC PMC4385443

Open this paper in CoChat — free account

Abstract

Opioids are the most potent analgesics in clinical use; however, their powerful rewarding properties can lead to addiction. The scientific challenge is to retain analgesic potency while limiting the development of tolerance, dependence, and addiction. Both rewarding and analgesic actions of opioids depend upon actions at the mu opioid (MOP) receptor. Systemic opioid reward requires MOP receptor function in the midbrain ventral tegmental area (VTA) which contains dopaminergic neurons. VTA dopaminergic neurons are implicated in various aspects of reward including reward prediction error, working memory, and incentive salience. It is now clear that subsets of VTA neurons have different pharmacological properties and participate in separate circuits. The degree to which MOP receptor agonists act on different VTA circuits depends upon the behavioral state of the animal, which can be altered by manipulations such as food deprivation or prior exposure to MOP receptor agonists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.tins.2015.01.002

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
Dopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396
Dopamine neuron systems in the brain: An update
Björklund, A., & Dunnett, S. B. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.006 · Cited by 1,777
The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat
Swanson, L. W. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90145-9 · Cited by 1,718
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
The mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Neuron-type-specific signals for reward and punishment in the ventral tegmental area
Cohen, J. Y., Haesler, S., Vong, L., Lowell, B. B., & Uchida, N. (2012) · Nature · doi:10.1038/nature10754 · Cited by 1,318
Input-specific control of reward and aversion in the ventral tegmental area
Lammel, S., Lim, B. K., Ran, C., Huang, K. W., Betley, M. J., Tye, K. M., Deisseroth, K., & Malenka, R. C. (2012) · Nature · doi:10.1038/nature11527 · Cited by 1,300

Show all 131 references

Sorted by citations

The theory of constructed emotion: an active inference account of interoception and categorization
Barrett, L. F. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw154 · Cited by 1,426
“Other neuromodulators, such as opioids, seem to be more intrinsic to reward in that regard (e.g. Fields and Margolis, 2015).”
Ventral tegmental area: cellular heterogeneity, connectivity and behaviour
Morales, M., & Margolis, E. B. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.165 · Cited by 1,108
Self-citation
The theory of constructed emotion: an active inference account of interoception and categorization
Barrett, L. F. (2017) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsx060 · Cited by 1,009
“Other neuromodulators, such as opioids, seem to be more intrinsic to reward in that regard (e.g. Fields and Margolis, 2015).”
The Neuroscience of Drug Reward and Addiction
Volkow, N. D., Michaelides, M., & Baler, R. (2019) · Physiological Reviews · doi:10.1152/physrev.00014.2018 · Cited by 863
An active inference theory of allostasis and interoception in depression
Barrett, L. F., Quigley, K. S., & Hamilton, P. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0011 · Cited by 554
Perioperative opioid analgesia—when is enough too much? A review of opioid-induced tolerance and hyperalgesia
Colvin, L., Bull, F. A., & Hales, T. G. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30430-1 · Cited by 602
Endogenous and Exogenous Opioids in Pain
Corder, G. F., Castro, D. C., Bruchas, M. R., & Scherrer, G. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061522 · Cited by 537
Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care
Tick, H., Nielsen, A., Pelletier, K. R., Bonakdar, R. A., Simmons, S., Glick, R. M., Ratner, E. F., Lemmon, R., Wayne, P. M., & Zador, V. (2018) · EXPLORE · doi:10.1016/j.explore.2018.02.001 · Cited by 404
Opioid receptors: drivers to addiction?
Darcq, E., & Kieffer, B. L. (2018) · Nature reviews. Neuroscience · doi:10.1038/s41583-018-0028-x · Cited by 365
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics
Trang, T., Al‐Hasani, R., Salvemini, D., Salter, M. W., Gutstein, H. B., & Cahill, C. M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2711-15.2015 · Cited by 290
Frontostriatal Gating of Tinnitus and Chronic Pain
Rauschecker, J. P., May, E. S., Maudoux, A., & Ploner, M. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.08.002 · Cited by 261
Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use
Calcaterra, S. L., Yamashita, T. E., Min, S.-J., Keniston, A., Frank, J. W., & Binswanger, I. A. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3539-4 · Cited by 236
Brain circuits for pain and its treatment
Lindsay, N. M., Chen, C., Gilam, G., Mackey, S., & Scherrer, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj7360 · Cited by 246
Mesolimbic dopamine signaling in acute and chronic pain
Taylor, A. M. W., Becker, S., Schweinhardt, P., & Cahill, C. M. (2016) · Pain · doi:10.1097/j.pain.0000000000000494 · Cited by 248
Chapter 1. Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb01 · Cited by 236
Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure
Juarez, B., & Han, M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.32 · Cited by 176
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling
Wenzel, J. M., & Cheer, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.126 · Cited by 161
Navigating for reward
Sosa, M., & Giocomo, L. M. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00479-z · Cited by 146
Sex Differences and the Role of Estradiol in Mesolimbic Reward Circuits and Vulnerability to Cocaine and Opiate Addiction
Kokane, S. S., & Perrotti, L. I. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00074 · Cited by 132
The role of the opioid system in decision making and cognitive control: a review
van Steenbergen, H., Eikemo, M., & Leknes, S. (2019) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-019-00710-6 · Cited by 118
Allostatic mechanisms of opioid tolerance beyond desensitization and downregulation
Cahill, C. M., Walwyn, W., Taylor, A. M. W., Pradhan, A. A. A., & Evans, C. J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.002 · Cited by 122
A feedback neural circuit for calibrating aversive memory strength
Ozawa, T., Ycu, E. A., Kumar, A., Yeh, L.-F., Ahmed, T., Koivumaa, J., & Johansen, J. P. (2016) · Nature Neuroscience · doi:10.1038/nn.4439 · Cited by 129
Astrocyte EV-Induced lincRNA-Cox2 Regulates Microglial Phagocytosis: Implications for Morphine-Mediated Neurodegeneration
Hu, G., Liao, K., Niu, F., Yang, L., Dallon, B. W., Callen, S. E., Tian, C., Shu, J., Cui, J., Sun, Z., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.019 · Cited by 117
Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors
Hipólito, L., Wilson‐Poe, A. R., Campos‐Jurado, Y., Zhong, E., González-Romero, J. L., Virag, L., Whittington, R. A., Comer, S. D., Carlton, S. M., Walker, B. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1053-15.2015 · Cited by 114
Brain Reward Circuits in Morphine Addiction
Kim, J., Ham, S., Hong, H., Moon, C., & Im, H. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0137 · Cited by 117
Evidence and explanation for the involvement of the nucleus accumbens in pain processing
Harris, H. N., & Peng, Y. B. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266909 · Cited by 108
Chemogenetic Manipulations of Ventral Tegmental Area Dopamine Neurons Reveal Multifaceted Roles in Cocaine Abuse
Mahler, S. V., Brodnik, Z. D., Cox, B. M., Buchta, W. C., Bentzley, B. S., Quintanilla, J., Cope, Z. A., Lin, E. C., Riedy, M. D., Scofield, M. D., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0537-18.2018 · Cited by 104
Regulation of morphine-induced synaptic alterations: Role of oxidative stress, ER stress, and autophagy
Cai, Y. C., Yang, L., Hu, G., Chen, X., Niu, F., Yuan, L., Liu, H., Xiong, H., Arikkath, J., & Buch, S. J. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201605065 · Cited by 100
Dissecting the Role of GABA Neurons in the VTA versus SNr in Opioid Reward
Galaj, E., Han, X., Shen, H., Jordan, C. J., He, Y., Humburg, B. A., Bi, G., & Xi, Z. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0988-20.2020 · Cited by 97
Projection specificity in heterogeneous locus coeruleus cell populations: implications for learning and memoryPreprint
Uematsu, A., Tan, B. Z., & Johansen, J. P. (2015) · Learning & Memory · doi:10.1101/lm.037283.114 · Cited by 89
The Role of Glutamatergic and Dopaminergic Neurons in the Periaqueductal Gray/Dorsal Raphe: Separating Analgesia and Anxiety
Taylor, N. E., Pei, J., Zhang, J., Vlasov, K. Y., Davis, T., Taylor, E., Weng, F., Dort, C. J. V., Solt, K., & Brown, E. N. (2019) · eNeuro · doi:10.1523/eneuro.0018-18.2019 · Cited by 93
Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats
Neelakantan, H., Holliday, E. D., Fox, R. G., Stutz, S. J., Comer, S. D., Haney, M., Anastasio, N. C., Moeller, F. G., & Cunningham, K. A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00413 · Cited by 90
Anatomy and Function of Ventral Tegmental Area Glutamate Neurons
Cai, J., & Tong, Q. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.867053 · Cited by 101
Junk food-induced obesity- a growing threat to youngsters during the pandemic
Ankul Singh, S., Dhanasekaran, D., Ganamurali, N., Preethi, L., & Sabarathinam, S. (2021) · Obesity Medicine · doi:10.1016/j.obmed.2021.100364 · Cited by 86
Food Addiction and Binge Eating: Lessons Learned from Animal Models
Novelle, M. G., & Diéguez, C. (2018) · Nutrients · doi:10.3390/nu10010071 · Cited by 90
Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain
Abraham, A. D., Leung, E. J. Y., Wong, B. A., Rivera, Z. M. G., Kruse, L. C., Clark, J. J., & Land, B. B. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0585-3 · Cited by 84
A neurobehavioral approach to addiction: implications for the opioid epidemic and the psychology of addiction
Bechara, A., Berridge, K. C., Bickel, W. K., Morón, J. A., Williams, S. B., & Stein, J. S. (2019) · Psychological Science in the Public Interest · doi:10.1177/1529100619860513 · Cited by 82
The highly selective dopamine D R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents
Jordan, C. J., Humburg, B. A., RICE, M. S., Bi, G., You, Z., Shaik, A. B., Cao, J., Bonifazi, A., Gadiano, A. J., Rais, R., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.003 · Cited by 82
Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects
You, Z., Bi, G., Galaj, E., Kumar, V., Cao, J., Gadiano, A. J., Rais, R., Slusher, B. S., Gardner, E. L., Xi, Z., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0284-5 · Cited by 82
The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models
Welsch, L., Bailly, J., Darcq, E., & Kieffer, B. L. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.027 · Cited by 84
Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis
Baldo, B. A. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.03.004 · Cited by 76
Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability
Karjalainen, T., Tuominen, L. J., Manninen, S., Kalliokoski, K. K., Nuutila, P., Jääskeläinen, I. P., Hari, R., Sams, M. E., & Nummenmaa, L. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw044 · Cited by 76
G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder
Gutridge, A. M., Robins, M. T., Cassell, R. J., Uprety, R., Mores, K. L., Ko, M. J., Pasternak, G. W., Majumdar, S., & van Rijn, R. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14913 · Cited by 79
Glucagon-like peptide-1 receptor agonist treatment does not reduce abuse-related effects of opioid drugs
Bornebusch, A. B., Fink-Jensen, A., Wörtwein, G., Seeley, R. J., & Thomsen, M. (2019) · eneuro · doi:10.1523/eneuro.0443-18.2019 · Cited by 72
Mu opioid receptors in the medial habenula contribute to naloxone aversion
Boulos, L., Hamida, S. B., Bailly, J., Maitra, M., Ehrlich, A. T., Gavériaux‐Ruff, C., Darcq, E., & Kieffer, B. L. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0395-7 · Cited by 73
Rostral and Caudal Ventral Tegmental Area GABAergic Inputs to Different Dorsal Raphe Neurons Participate in Opioid Dependence
Li, Y., Li, C., Wang, X., Jin, S., Wu, Z.-H., Jiang, P., Dong, P., He, X., Xu, F., Duan, S., et al. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.012 · Cited by 74
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
Jordan, C. J., Cao, J., Newman, A. H., & Xi, Z. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.015 · Cited by 70
Serotonin-1A receptor dependent modulation of pain and reward for improving therapy of chronic pain
Haleem, D. J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.030 · Cited by 68
Mu Opioid Receptors in Gamma-Aminobutyric Acidergic Forebrain Neurons Moderate Motivation for Heroin and Palatable Food
Charbogne, P., Gardon, O., Martín‐García, E., Keyworth, H. L., Matsui, A., Mechling, A. E., Bienert, T., Nasseef, M. T., Robé, A., Moquin, L., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.022 · Cited by 75
Morphine Induces Apoptosis, Inflammation, and Mitochondrial Oxidative Stress via Activation of TRPM2 Channel and Nitric Oxide Signaling Pathways in the Hippocampus
Osmanlıoğlu, H. Ö., Yıldırım, M. K., Akyuva, Y., Yıldızhan, K., & Nazıroğlu, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01975-6 · Cited by 68
Pain tolerance predicts human social network size
Johnson, K. V.-A., & Dunbar, R. I. M. (2016) · Scientific Reports · doi:10.1038/srep25267 · Cited by 65
Behavioral sex differences in cocaine and opioid use disorders: The role of gonadal hormones
Knouse, M. C., & Briand, L. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.038 · Cited by 61
Opioid-induced microglia reactivity modulates opioid reward, analgesia, and behavior
Green, J. M., Sundman, M., & Chou, Y. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104544 · Cited by 63
Studying Synaptic Connectivity and Strength with Optogenetics and Patch-Clamp Electrophysiology
Linders, L. E., Supiot, L. F., Du, W., D’Angelo, R., Adan, R. A. H., Riga, D., & Meye, F. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911612 · Cited by 66
From Pleasure to Pain, and Back Again: The Intricate Relationship Between Alcohol and Nociception
Robins, M. T., Heinricher, M. M., & Ryabinin, A. E. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz067 · Cited by 63
Sex Differences in Opioid-Mediated Effects: Role of Androgens
Sharp, J. L., Pearson, T., & Smith, M. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104522 · Cited by 60
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine
Kaski, S. W., White, A., Gross, J., Trexler, K. R., Wix, K., Harland, A. A., Prisinzano, T. E., Aubé, J., Kinsey, S. G., Kenakin, T., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255661 · Cited by 59
Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges
Galaj, E., Newman, A. H., & Xi, Z. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.024 · Cited by 56
Targeting Morphine-Responsive Neurons: Generation of a Knock-In Mouse Line Expressing Cre Recombinase from the Mu-Opioid Receptor Gene Locus
Bailly, J., Rossi, N. D., Runtz, L., Li, J., Park, D., Scherrer, G., Tanti, A., Birling, M., Darcq, E., & Kieffer, B. L. (2020) · eNeuro · doi:10.1523/eneuro.0433-19.2020 · Cited by 54
Crosstalk between Mu-Opioid receptors and neuroinflammation: Consequences for drug addiction and pain
Cuitavi, J., Torres-Pérez, J. V., Lorente, J. D., Campos‐Jurado, Y., Andrés‐Herrera, P., Polache, A., Agustín‐Pavón, C., & Hipólito, L. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.105011 · Cited by 55
Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse
Kiguchi, N., Ding, H., & Ko, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24624 · Cited by 54
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion
Margolis, E. B., & Karkhanis, A. N. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104504 · Cited by 56
Self-citation
Song practice as a rewarding form of play in songbirds
Riters, L. V., Spool, J. A., Merullo, D. P., & Hahn, A. H. (2017) · Behavioural Processes · doi:10.1016/j.beproc.2017.10.002 · Cited by 54
Pharmacogenomics of Oxycodone: A Narrative Literature Review
Umukoro, N. N., Aruldhas, B. W., Rossos, R., Pawale, D., Renschler, J. S., & Sadhasivam, S. (2021) · Pharmacogenomics · doi:10.2217/pgs-2020-0143 · Cited by 50
Lysergic Acid Diethylamide and Psilocybin for the Management of Patients with Persistent Pain: a Potential Role?
Whelan, A., & Johnson, M. I. (2018) · Pain Management · doi:10.2217/pmt-2017-0068 · Cited by 51
Different neuronal populations mediate inflammatory pain analgesia by exogenous and endogenous opioids
Zhang, X., Dou, Y., Yuan, L., Li, Q., Zhu, Y., Wang, M., & Sun, Y.-G. (2020) · eLife · doi:10.7554/elife.55289 · Cited by 52
Ghrelin receptor antagonism of fentanyl‐induced conditioned place preference, intravenous self‐administration, and dopamine release in the nucleus accumbens in rats
Šustková-Fišerová, M., Puskina, N., Havlickova, T., Lapka, M., Syslová, K., Pohorala, V., & Charalambous, C. (2019) · Addiction Biology · doi:10.1111/adb.12845 · Cited by 50
Enhanced heroin self-administration and distinct dopamine adaptations in female rats
George, B. E., Barth, S. H., Kuiper, L. B., Holleran, K. M., Lacy, R. T., Raab‐Graham, K. F., & Jones, S. R. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01035-0 · Cited by 52
The Glasgow Coma Scale and evidence‐informed practice: a critical review of where we are and where we need to be
Braine, M. E., & Cook, N. F. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13390 · Cited by 49
Glial neuroimmune signaling in opioid reward
Zhang, H., Largent‐Milnes, T. M., & Vanderah, T. W. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.012 · Cited by 50
Opiates and Plasticity in the Ventral Tegmental Area
Langlois, L. D., & Nugent, F. S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00281 · Cited by 49
Immunosuppression by opioids: Mechanisms of action on innate and adaptive immunity
Sun, Q., Li, Z., Wang, Z., Wang, Q., Qin, F., Pan, H., Lin, W., Mu, X., Wang, Y., Jiang, Y., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115417 · Cited by 47
Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats
Carpenter, J. M., Criddle, C. A., Craig, H. K., Ali, Z., Zhang, Z., Khan, I. A., & Sufka, K. J. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.12.001 · Cited by 42
Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine
Kudla, L., Bugno, R., Skupio, U., Wiktorowska, L., Solecki, W., Wojtas, A., Gołembiowska, K., Zádor, F., Benyhe, S., Buda, S., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14805 · Cited by 42
The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment
Brady, K. T., LEVIN, F. R., Galanter, M. S., & Kleber, H. D. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970 · Cited by 41
Mu opioid receptors in GABAergic neurons of the forebrain promote alcohol reward and drinking
Hamida, S. B., Boulos, L., McNicholas, M., Charbogne, P., & Kieffer, B. L. (2017) · Addiction Biology · doi:10.1111/adb.12576 · Cited by 38
Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization
Blum, K., Gondré‐Lewis, M. C., Modestino, E. J., Lott, L., Baron, D. A., Siwicki, D., McLaughlin, T., Howeedy, A., Krengel, M., Oscar‐Berman, M., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1600-8 · Cited by 43
Chronic heroin use disorder and the brain: Current evidence and future implications
Tolomeo, S., Steele, J. D., Ekhtiari, H., & Baldacchino, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110148 · Cited by 45
Opioid Modulation of Value-Based Decision-Making in Healthy Humans
Eikemo, M., Biele, G., Willoch, F., Thomsen, L., & Leknes, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.58 · Cited by 39
Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain
Zhu, C., Lan, X., Wei, Z., Yu, J., & Zhang, J. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.020 · Cited by 39
The rostromedial tegmental nucleus: a key modulator of pain and opioid analgesia
Taylor, N. E., Long, H., Pei, J., Kukutla, P., Phero, A., Hadaegh, F., Abdelnabi, A., Solt, K., & Brenner, G. J. (2019) · Pain · doi:10.1097/j.pain.0000000000001647 · Cited by 41
Pain-related cortico-limbic plasticity and opioid signaling
Neugebauer, V., Presto, P., Yakhnitsa, V., Antenucci, N., Mendoza, B., & Ji, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109510 · Cited by 38
A mu-opioid feedback model of human social behavior
Meier, I. M., van Honk, J., Bos, P. A., & Terburg, D. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.013 · Cited by 36
From safety to frustration: The neural substrates of inhibitory learning in aversive and appetitive conditioning procedures
Cassaday, H. J., Muir, C., Stevenson, C. W., Bonardi, C., Hock, R. M., & Waite, L. J. (2023) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2023.107757 · Cited by 36
Members of the same pharmacological family are not alike: Different opioids, different consequences, hope for the opioid crisis?
Emery, M. A., & Eitan, S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.010 · Cited by 36
The neurochemistry of social reward during development: What have we learned from rodent models?
Manduca, A., Carbone, E., Schiavi, S., Cacchione, C., Buzzelli, V., Campolongo, P., & Trezza, V. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15321 · Cited by 34
Interplay between the oxytocin and opioid systems in regulating social behaviour
Putnam, P. T., & Chang, S. W. C. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0050 · Cited by 33
Toll-Like Receptor 4 Signaling and Drug Addiction
Wu, R., & Li, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603445 · Cited by 36
Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens
Selleck, R. A., & Baldo, B. A. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4522-4 · Cited by 34
Behavioral, neurobiological, and neurochemical mechanisms of ethanol self-administration: A translational review
Vena, A. A., Zandy, S. L., Cofresí, R. U., & Gonzales, R. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107573 · Cited by 33
Mu opioid receptors on vGluT2‐expressing glutamatergic neurons modulate opioid reward
Reeves, K. C., Kube, M. J., Grecco, G. G., Fritz, B. M., Muñoz, B., Yin, F., Gao, Y., Haggerty, D. L., Hoffman, H., & Atwood, B. K. (2020) · Addiction Biology · doi:10.1111/adb.12942 · Cited by 34
The Periaqueductal Gray and Its Extended Participation in Drug Addiction Phenomena
Vázquez-León, P., Miranda-Páez, A., Chávez‐Reyes, J., Allende, G., Barragán‐Iglesias, P., & Marichal‐Cancino, B. A. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00756-y · Cited by 36
The role of CA3‐LS‐VTA loop in the formation of conditioned place preference induced by context‐associated reward memory for morphine
Jiang, J., Liu, H., Huang, Z., Cui, Y., Zhang, X., Zhang, X., Cui, Y., & Xin, W. (2016) · Addiction Biology · doi:10.1111/adb.12468 · Cited by 33
Morphine activation of mu opioid receptors causes disinhibition of neurons in the ventral tegmental area mediated by β-arrestin2 and c-Src
Bull, F. A., Baptista‐Hon, D. T., Lambert, J. J., Walwyn, W. M., & Hales, T. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10360-8 · Cited by 33
The Thalamus Regulates Retinoic Acid Signaling and Development of Parvalbumin Interneurons in Postnatal Mouse Prefrontal Cortex
Larsen, R., Proue, A., Scott, E. P., Christiansen, M., & Nakagawa, Y. (2019) · eNeuro · doi:10.1523/eneuro.0018-19.2019 · Cited by 31
Potential for Kappa-Opioid Receptor Agonists to Engineer Nonaddictive Analgesics: A Narrative Review
Kaski, S. W., White, A., Gross, J., & Siderovski, D. P. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005309 · Cited by 32
Shared Mechanisms of GABAergic and Opioidergic Transmission Regulate Corticolimbic Reward Systems and Cognitive Aspects of Motivational Behaviors
Sahafi, O. H., Sardari, M., Alijanpour, S., & Rezayof, A. (2023) · Brain Sciences · doi:10.3390/brainsci13050815 · Cited by 33
Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder
Shi, Z., Wang, A.-L., Jagannathan, K., Fairchild, V. P., O’Brien, C. P., Childress, A. R., & Langleben, D. D. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170036 · Cited by 31
Alterations and interactions of subcortical modulatory systems in Alzheimer's disease
Leko, M. B., Hof, P. R., & Šimić, G. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2020.07.016 · Cited by 31
Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors
Elvir, L., Duclot, F., Wang, Z., & Kabbaj, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.030 · Cited by 33

Authors: Fields, H. L., & Margolis, E. B.
Affiliations: University of California, San Francisco (US)
Corresponding author: Fields, Howard L.
ORCID: Fields, Howard L.
Margolis, Elyssa B.
Venue: Trends in Neurosciences
Publisher: Elsevier BV
Published: 2015-04
Volume: 38
Issue: 4
Pages: 217-225
ISSN: 0166-2236 (ISSN-L)
DOI: 10.1016/j.tins.2015.01.002
PMC: PMC4385443
OpenAlex: W2035419353
Cited by: 432
References: 131
Citations by year: 2026: 23 · 2025: 33 · 2024: 22 · 2023: 36 · 2022: 37 · 2021: 93 · 2020: 43 · 2019: 50 · 2018: 31 · 2017: 26 · 2016: 23 · 2015: 15
FWCI: 3.77
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Neurosciences (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute on Drug Abuse (R01DA029776)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: opioid reward, mu-opioid receptor, ventral tegmental area, dopaminergic neurons, opioid use disorder, analgesia, reward prediction error, incentive salience, working memory, behavioral state, food deprivation, opioid tolerance
MeSH terms: Analgesics, Opioid, Animals, Humans, Receptors, Opioid, Reinforcement, Psychology, Reward, Receptors, Opioid, mu, Ventral Tegmental Area, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Understanding opioid reward

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks